Related Experiment Videos

[Hormonal and metabolic disorders in ischemic heart disease]

Kardiologiia
|December 1, 1978
PubMed

Insights

Patients with ischemic heart disease and hypertension show elevated cholesterol, triglycerides, and glucose. Hormonal-metabolic shifts suggest primary role of hormonal regulation in atherogenesis.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Disorders

Background:

  • Ischemic heart disease (IHD) and hypertensive disease are significant health concerns.
  • Atherosclerosis of coronary arteries underlies many cases of IHD.
  • Understanding the metabolic and hormonal underpinnings is crucial for effective management.

Purpose of the Study:

  • To investigate metabolic and hormonal profiles in patients with IHD and hypertensive disease.
  • To explore the potential role of hormonal-regulatory disorders in atherogenesis.

Main Methods:

  • Observation of 440 IHD patients, 52 hypertensive patients with IHD-like symptoms, and 192 healthy controls.
  • Measurement of blood levels of cholesterol, triglycerides, and glucose.
  • Assessment of hormonal-metabolic shifts in patient groups.

Main Results:

  • Significantly increased levels of cholesterol, triglycerides, and glucose were observed in IHD and hypertensive patients compared to controls.
  • Patients with IHD (especially with pain and rhythm disorders) and hypertensive patients exhibited similar hormonal-metabolic shifts.
  • These findings indicate a common underlying pathophysiology.

Conclusions:

  • Hormonal-regulatory disorders appear to play a primary role in the development of atherosclerosis (atherogenesis).
  • The observed metabolic and hormonal changes highlight potential therapeutic targets.
  • Further research into hormonal regulation is warranted for IHD and hypertensive disease prevention and treatment.

Related Concept Videos